{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:23:35Z","timestamp":1794608615267,"version":"4.9.1"},"reference-count":68,"publisher":"BMJ","issue":"15","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Sports Med"],"accepted":{"date-parts":[[2021,2,4]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We systemically reviewed the literature to assess how long-term testosterone suppressing gender-affirming hormone therapy influenced lean body mass (LBM), muscular area, muscular strength and haemoglobin (Hgb)\/haematocrit (HCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Four databases (BioMed Central, PubMed, Scopus and Web of Science) were searched in April 2020 for papers from 1999 to 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria for selecting studies<\/jats:title>\n                    <jats:p>Eligible studies were those that measured at least one of the variables of interest, included transwomen and were written in English.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-four studies were identified and reviewed. Transwomen experienced significant decreases in all parameters measured, with different time courses noted. After 4 months of hormone therapy, transwomen have Hgb\/HCT levels equivalent to those of cisgender women. After 12 months of hormone therapy, significant decreases in measures of strength, LBM and muscle area are observed. The effects of longer duration therapy (36 months) in eliciting further decrements in these measures are unclear due to paucity of data. Notwithstanding, values for strength, LBM and muscle area in transwomen remain above those of cisgender women, even after 36 months of hormone therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In transwomen, hormone therapy rapidly reduces Hgb to levels seen in cisgender women. In contrast, hormone therapy decreases strength, LBM and muscle area, yet values remain above that observed in cisgender women, even after 36 months. These findings suggest that strength may be well preserved in transwomen during the first 3 years of hormone therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjsports-2020-103106","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T13:20:20Z","timestamp":1614604820000},"page":"865-872","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":140,"title":["How does hormone transition in transgender women change body composition, muscle strength and haemoglobin? Systematic review with a focus on the implications for sport participation"],"prefix":"10.1136","volume":"55","author":[{"given":"Joanna","family":"Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Sorouri Khorashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-2441","authenticated-orcid":false,"given":"Gemma L","family":"Witcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"2024051414414049000_55.15.865.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.25.1.17"},{"key":"2024051414414049000_55.15.865.2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00007256-199316050-00002","article-title":"Gender verification in competitive sports","volume":"16","author":"Simpson","year":"1993","journal-title":"Sports Med"},{"key":"2024051414414049000_55.15.865.3","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-098511"},{"key":"2024051414414049000_55.15.865.4","unstructured":"International Olympic Committee . IOC consensus meeting on sex reassignment and hyperandrogenism, 2015. Available: https:\/\/stillmed.olympic.org\/Documents\/Commissions_PDFfiles\/Medical_commission\/201511_ioc_consensus_meeting_on_sex_reassignment_and_hyperandrogenism-en.pdf"},{"key":"2024051414414049000_55.15.865.5","unstructured":"World Athletics . Eligibility regulations transgender regulation, 2019. Available: https:\/\/www.worldathletics.org\/about-iaaf\/documents\/book-of-rules"},{"key":"2024051414414049000_55.15.865.6","unstructured":"World Athletics . Eligibility regulations for the female classification, 2019. Available: https:\/\/www.worldathletics.org\/about-iaaf\/documents\/book-of-rules"},{"key":"2024051414414049000_55.15.865.7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11673-018-9876-3","article-title":"Impossible \"Choices\": The Inherent Harms of Regulating Women's Testosterone in Sport","volume":"15","author":"Karkazis","year":"2018","journal-title":"J Bioeth Inq"},{"key":"2024051414414049000_55.15.865.8","unstructured":"Hutcheon D . Hyperandrogenism in athletics: a review of Chand V. IAAF. law in sport, 2015. Available: https:\/\/www.lawinsport.com\/topics\/item\/hyperandrogenism-in-athletics-a-review-of-chand-v iaaf"},{"key":"2024051414414049000_55.15.865.9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15265161.2012.680533","article-title":"Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes","volume":"12","author":"Karkazis","year":"2012","journal-title":"Am J Bioeth"},{"key":"2024051414414049000_55.15.865.10","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.radi.2019.10.008","article-title":"A qualitative study of transgender individuals' experiences of healthcare including radiology","volume":"26","author":"Floyd","year":"2020","journal-title":"Radiography"},{"key":"2024051414414049000_55.15.865.11","doi-asserted-by":"crossref","unstructured":"Buzuvis E . Challenging gender in Single-Sex spaces: lessons from a feminist Softball League. law and contemporary problems. Sex in Sport 2017;80.","DOI":"10.31228\/osf.io\/38cwn"},{"key":"2024051414414049000_55.15.865.12","doi-asserted-by":"publisher","DOI":"10.1177\/0004563215587763"},{"key":"2024051414414049000_55.15.865.13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/er.2018-00011","article-title":"Endocrinology of transgender medicine","volume":"40","author":"T'Sjoen","year":"2019","journal-title":"Endocr Rev"},{"key":"2024051414414049000_55.15.865.14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jbmr.3612","article-title":"Bone safety during the first ten years of Gender-Affirming hormonal treatment in Transwomen and Transmen","volume":"34","author":"Wiepjes","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2024051414414049000_55.15.865.15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0496"},{"key":"2024051414414049000_55.15.865.16","doi-asserted-by":"crossref","first-page":"e805","DOI":"10.1210\/clinem\/dgz247","article-title":"Muscle strength, size, and composition following 12 months of Gender-affirming treatment in transgender individuals","volume":"105","author":"Wiik","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024051414414049000_55.15.865.17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1530\/EC-19-0196","article-title":"Change in grip strength in trans people and its association with lean body mass and bone density","volume":"8","author":"Scharff","year":"2019","journal-title":"Endocr Connect"},{"key":"2024051414414049000_55.15.865.18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2019.02.011","article-title":"Hematology reference intervals for transgender adults on stable hormone therapy","volume":"492","author":"Greene","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2024051414414049000_55.15.865.19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/andr.12485","article-title":"Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European network for the investigation of gender incongruence","volume":"6","author":"Defreyne","year":"2018","journal-title":"Andrology"},{"key":"2024051414414049000_55.15.865.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104747"},{"key":"2024051414414049000_55.15.865.21","doi-asserted-by":"publisher","DOI":"10.1186\/2046-7648-2-33"},{"key":"2024051414414049000_55.15.865.22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008290","article-title":"Relationship between hematocrit levels and intraocular pressure in men and women: a population-based cross-sectional study","volume":"96","author":"Cohen","year":"2017","journal-title":"Medicine"},{"key":"2024051414414049000_55.15.865.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1692"},{"key":"2024051414414049000_55.15.865.24","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"key":"2024051414414049000_55.15.865.25","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1519\/JSC.0000000000002149","article-title":"A brief review of handgrip strength and sport performance","volume":"31","author":"Cronin","year":"2017","journal-title":"J Strength Cond Res"},{"key":"2024051414414049000_55.15.865.26","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13350"},{"key":"2024051414414049000_55.15.865.27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913935107"},{"key":"2024051414414049000_55.15.865.28","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-199911000-00006"},{"key":"2024051414414049000_55.15.865.29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01658"},{"key":"2024051414414049000_55.15.865.30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/jcm8060784","article-title":"Systematic review of the long-term effects of transgender hormone therapy on bone markers and bone mineral density and their potential effects in implant therapy","volume":"8","author":"Delgado-Ruiz","year":"2019","journal-title":"JCM"},{"key":"2024051414414049000_55.15.865.31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/js.2018-00413","article-title":"Bone mass effects of Cross-Sex hormone therapy in transgender people: updated systematic review and meta-analysis","volume":"3","author":"Fighera","year":"2019","journal-title":"J Endocr Soc"},{"key":"2024051414414049000_55.15.865.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"2024051414414049000_55.15.865.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2010.01516.x"},{"key":"2024051414414049000_55.15.865.34","first-page":"CD012069","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","volume":"5","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2024051414414049000_55.15.865.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2004.04006.x"},{"key":"2024051414414049000_55.15.865.36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"2024051414414049000_55.15.865.37","doi-asserted-by":"crossref","DOI":"10.1038\/srep37005","article-title":"12-Months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study","volume":"6","author":"Auer","year":"2016","journal-title":"Sci Rep"},{"key":"2024051414414049000_55.15.865.38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jsxm.2017.03.251","article-title":"Consecutive cyproterone acetate and estradiol treatment in Late-Pubertal transgender female adolescents","volume":"14","author":"Tack","year":"2017","journal-title":"J Sex Med"},{"key":"2024051414414049000_55.15.865.39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/jc.2017-01559","article-title":"Effects of sex hormone treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines","volume":"103","author":"Auer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024051414414049000_55.15.865.40","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2017-02316","article-title":"Proandrogenic and antiandrogenic progestins in transgender youth: differential effects on body composition and bone metabolism","volume":"103","author":"Tack","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024051414414049000_55.15.865.41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00198-014-2805-3","article-title":"Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study","volume":"26","author":"Van Caenegem","year":"2015","journal-title":"Osteoporos Int"},{"key":"2024051414414049000_55.15.865.42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1999.276.2.E317"},{"key":"2024051414414049000_55.15.865.43","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510425"},{"key":"2024051414414049000_55.15.865.44","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1255074"},{"key":"2024051414414049000_55.15.865.45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1447-0756.2011.01815.x","article-title":"Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment","volume":"38","author":"","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"2024051414414049000_55.15.865.46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cen.13050","article-title":"Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness","volume":"85","author":"Gava","year":"2016","journal-title":"Clin Endocrinol"},{"key":"2024051414414049000_55.15.865.47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3173"},{"key":"2024051414414049000_55.15.865.48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.maturitas.2017.10.012","article-title":"Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: a cohort study","volume":"107","author":"Vita","year":"2018","journal-title":"Maturitas"},{"key":"2024051414414049000_55.15.865.49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jadohealth.2017.08.005","article-title":"Physiologic response to Gender-Affirming hormones among transgender youth","volume":"62","author":"Olson-Kennedy","year":"2018","journal-title":"J Adolesc Health"},{"key":"2024051414414049000_55.15.865.50","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1210\/jc.2018-02253","article-title":"Medroxyprogesterone acetate in Gender-Affirming therapy for Transwomen: results from a retrospective study","volume":"104","author":"Jain","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2024051414414049000_55.15.865.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2007.05.012"},{"key":"2024051414414049000_55.15.865.52","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.292730"},{"key":"2024051414414049000_55.15.865.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.10.009"},{"key":"2024051414414049000_55.15.865.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.09.001"},{"key":"2024051414414049000_55.15.865.55","doi-asserted-by":"publisher","DOI":"10.1080\/15532739.2011.700873"},{"key":"2024051414414049000_55.15.865.56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"2024051414414049000_55.15.865.57","unstructured":"Handelsman DJ . Performance Enhancing Hormone Doping in Sport. In: Feingold KR , Anawalt B , Boyce A , et al , eds. Endotext. South Dartmouth (MA): MDText.com, Inc, 2000."},{"key":"2024051414414049000_55.15.865.58","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-019-0257-3","article-title":"Muscle metabolism and atrophy: let's talk about sex","volume":"10","author":"Rosa-Caldwell","year":"2019","journal-title":"Biol Sex Differ"},{"key":"2024051414414049000_55.15.865.59","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114517002665"},{"key":"2024051414414049000_55.15.865.60","doi-asserted-by":"crossref","first-page":"7302205080p1","DOI":"10.5014\/ajot.2019.029538","article-title":"Handgrip strength: a comparison of values obtained from the NHANES and NIH Toolbox studies","volume":"73","author":"Bohannon","year":"2019","journal-title":"Am J Occup Ther"},{"key":"2024051414414049000_55.15.865.61","doi-asserted-by":"publisher","DOI":"10.2519\/jospt.1999.29.2.116"},{"key":"2024051414414049000_55.15.865.62","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00332"},{"key":"2024051414414049000_55.15.865.63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18848\/2381-6678\/CGP\/v06i01\/54079","article-title":"Race times for transgender athletes","volume":"6","author":"Harper","year":"2015","journal-title":"Journal of Sporting Cultures and Identities"},{"key":"2024051414414049000_55.15.865.64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/erv.2362","article-title":"Body image dissatisfaction and eating-related psychopathology in trans individuals: a matched control study","volume":"23","author":"Witcomb","year":"2015","journal-title":"Eur Eat Disord Rev"},{"key":"2024051414414049000_55.15.865.65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/15532739.2017.1293581","article-title":"Barriers and facilitators of physical activity and sport participation among young transgender adults who are medically transitioning","volume":"18","author":"Jones","year":"2017","journal-title":"Int J Transgend"},{"key":"2024051414414049000_55.15.865.66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1981"},{"key":"2024051414414049000_55.15.865.67","article-title":"Effect of gender affirming hormones on athletic performance in transwomen and transmen: implications for sporting organisations and legislators","author":"Roberts","year":"2020","journal-title":"Br J Sports Med"},{"key":"2024051414414049000_55.15.865.68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1249\/JSR.0000000000000455","article-title":"Implications of a third gender for elite sports","volume":"17","author":"Harper","year":"2018","journal-title":"Curr Sports Med Rep"}],"container-title":["British Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjsports-2020-103106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:58:06Z","timestamp":1715709486000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjsm.bmj.com\/lookup\/doi\/10.1136\/bjsports-2020-103106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":68,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/bjsports-2020-103106"],"URL":"https:\/\/doi.org\/10.1136\/bjsports-2020-103106","relation":{},"ISSN":["0306-3674","1473-0480"],"issn-type":[{"value":"0306-3674","type":"print"},{"value":"1473-0480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}